 Nanoparticles
"Nanoparticles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging.
| Descriptor ID |
D053758
|
| MeSH Number(s) |
J01.637.512.600
|
| Concept/Terms |
Nanocrystalline Materials- Nanocrystalline Materials
- Material, Nanocrystalline
- Materials, Nanocrystalline
- Nanocrystalline Material
- Nanocrystals
- Nanocrystal
|
Below are MeSH descriptors whose meaning is more general than "Nanoparticles".
Below are MeSH descriptors whose meaning is more specific than "Nanoparticles".
This graph shows the total number of publications written about "Nanoparticles" by people in this website by year, and whether "Nanoparticles" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 0 | 2 | | 2007 | 4 | 1 | 5 | | 2008 | 5 | 2 | 7 | | 2009 | 17 | 6 | 23 | | 2010 | 8 | 5 | 13 | | 2011 | 18 | 2 | 20 | | 2012 | 11 | 7 | 18 | | 2013 | 16 | 2 | 18 | | 2014 | 9 | 5 | 14 | | 2015 | 25 | 4 | 29 | | 2016 | 9 | 5 | 14 | | 2017 | 12 | 8 | 20 | | 2018 | 15 | 1 | 16 | | 2019 | 16 | 5 | 21 | | 2020 | 10 | 7 | 17 | | 2021 | 19 | 3 | 22 | | 2022 | 16 | 2 | 18 | | 2023 | 17 | 0 | 17 | | 2024 | 31 | 6 | 37 | | 2025 | 15 | 8 | 23 |
To return to the timeline, click here.
Below are the most recent publications written about "Nanoparticles" by people in Profiles.
-
Joseph RA, Haley RM, Padilla MS, Ricciardi AS, Yamagata HM, Mitchell MJ. Cas9 Protein Outperforms mRNA in Lipid Nanoparticle-Mediated CFTR Repair. Nano Lett. 2025 Oct 01; 25(39):14348-14355.
-
Swingle KL, Hamilton AG, Han X, Liao KC, Safford HC, Thatte AS, Geisler HC, Xu J, Saw TY, Wan Y, Mitchell MJ. Circular RNA lipid nanoparticle vaccine against SARS-CoV-2. Proc Natl Acad Sci U S A. 2025 Sep 23; 122(38):e2505718122.
-
Murray AM, Swingle KL, Mitchell MJ. Engineering Nanoparticles for Gynecologic Cancer Therapy. ACS Nano. 2025 Sep 02; 19(34):30758-30785.
-
Johnson W, Mansfeldt C. Nanoparticulate Wood Treatments Contribute to the Aquatic Toxicity of Simulated Urban Wildfire Ashes. Environ Sci Technol. 2025 Aug 19; 59(32):17275-17285.
-
Nagaoka K, Nakanishi H, Tanaka H, Anindita J, Kawamura T, Tanaka T, Yamashita T, Kuroda A, Nomura S, Akita H, Itaka K, Kodama T, Kakimi K. Neoantigen mRNA vaccines induce progenitor-exhausted T cells that support anti-PD-1 therapy in gastric cancer with peritoneal metastasis. Gastric Cancer. 2025 Sep; 28(5):825-836.
-
Shuvaev VV, Tam YK, Lee BW, Myerson JW, Herbst A, Kiseleva RY, Glassman PM, Parhiz H, Alameh MG, Pardi N, Muramatsu H, Shuvaeva TI, Arguiri E, Marcos-Contreras OA, Hood ED, Brysgel TV, Nong J, Papp TE, Eaton DM, Riley R, Palanki R, Musunuru K, Brenner JS, Mitchell MJ, Ferrari VA, Mui BL, Semple SC, Weppler SA, Atluri P, Margulies KB, Weissman D, Muzykantov VR. Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo. Proc Natl Acad Sci U S A. 2025 Jul 22; 122(29):e2409266122.
-
Panja S, Zaman LA, Zhang C, Patel M, Gorantla S, Dash PK, Gendelman HE. Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV-1 Proviral DNA Excision. Adv Healthc Mater. 2025 Sep; 14(25):e2501190.
-
Li Y, Jacques S, Gaikwad H, Nebbia M, Banda NK, Holers VM, Tomlinson SA, Scheinman RI, Monte A, Saba L, Lasda E, Hasselberth J, Busquet N, Zelek WM, Moghimi SM, Simberg D. Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors. Sci Adv. 2025 Jul 11; 11(28):eadw1731.
-
Ray S, Jacques S, Ettah U, Dai S, Gaikwad HK, Scheinman RI, Mallela KMG, Simberg D. Magnetic Nanoworm-Based Screening of Yeast Library for Anti-PEG Nanobodies. Mol Pharm. 2025 Aug 04; 22(8):4909-4918.
-
Vadovics M, Zhao W, Daley EF, Lam K, Daly O, Rashid K, Lee HR, Schreiner P, Lundgreen KA, Gaudette BT, Shuvaev VV, Arguiri E, Muramatsu H, Sárközy A, Mdluli T, Xu J, Han X, De Luna N, Castaño D, Bettini E, Ábrahám E, Lipinszki Z, Carlucci G, Bansode AH, Nguyen K, Le TM, Luu T, Muzykantov VR, Bates P, Allman D, Mitchell MJ, Locci M, Radu CG, Heyes J, Pardi N. Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications. Nat Nanotechnol. 2025 Sep; 20(9):1312-1322.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|